Substance / Medication

Gentamicin

Overview

Active Ingredient
gentamicin
RxNorm CUI
1596450

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

97 trials linked to this intervention

97
Total Trials
26
Recruiting
8
With Results

Research Evidence

Published studies and systematic reviews

Sort:
A systematic review and meta-analysis of intratympanic gentamicin for patients with Ménières disease.
Devantier Louise, Callesen Henriette Edemann, Hougaard Dan Dupont et al. · Acta Otolaryngol · 2025
PMID: 40421807Meta-Analysis
The effect of intratympanic gentamicin as a prehabilitation strategy for objective and subjective vestibular function in patients undergoing microsurgery for a unilateral vestibular schwannoma.
Fuentealba Bassaletti Constanza, van Esch Babette F, Jansen Jeroen C et al. · Eur Arch Otorhinolaryngol · 2024
PMID: 37750993Meta-AnalysisFull text (PMC)
Pharmacokinetics of ceftriaxone, gentamicin, meropenem and vancomycin in liver cirrhosis: a systematic review.
Comce M H, Weersink R A, Beuers U et al. · J Antimicrob Chemother · 2024
PMID: 39289819Meta-AnalysisFull text (PMC)
Pre-habilitation with intratympanic gentamicin in vestibular schwannomas: a systematic review.
Potdar T, Kontorinis G · J Laryngol Otol · 2023
PMID: 37185086Meta-Analysis
Intratympanic gentamicin for Ménière's disease.
Webster Katie E, Galbraith Kevin, Lee Ambrose et al. · Cochrane Database Syst Rev · 2023
PMID: 36847592Meta-AnalysisFull text (PMC)
Effects of intratympanic gentamicin and intratympanic glucocorticoids in Ménière's disease: a network meta-analysis.
Hao Weiming, Yu Huiqian, Li Huawei · J Neurol · 2022
PMID: 33387016Meta-Analysis
Intratympanic gentamicin compared with placebo for Ménière's disease.
de Amesti Fernanda, Santander Maria Jesus, Winter Matias · Medwave · 2022
PMID: 35323825Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Gentamicin (substance)
SNOMED CT
387321007
UMLS CUI
C3854019
RxNorm CUI
1596450

Clinical Data

This intervention maps to 16 entities in the Ltrl knowledge graph.

16
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
97
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.